NCT04964895 2025-12-17
QSCO
University Hospital, Toulouse
Completed
Clinical Trials
12 trialsNCT01697566 2025-06-11
An Endometrial Cancer Chemoprevention Study of Metformin
M.D. Anderson Cancer Center
Phase 3 Completed
NCT01832402 2023-06-08
Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT05843955 2023-05-09
Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
Hacettepe University
Completed
NCT01670097 2021-02-17
Dexamethasone Dyspnea Study
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01856114 2020-09-16
Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01870947 2020-01-27
Assisted Exercise in Obese Endometrial Cancer Patients
Case Comprehensive Cancer Center
Phase NA Completed
NCT02422329 2018-03-22
Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention
M.D. Anderson Cancer Center
Phase NA Completed
NCT00614276 2015-01-09
Female Sexual Dysfunction Intervention
M.D. Anderson Cancer Center
Completed
NCT01515566 2014-08-22
Breakthrough Dyspnea Fentanyl Study in Cancer Patients
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT01031602 2013-05-29
Assessment of Sexual Dysfunction, Depression and Anxiety in Underserved, Minority Gynecologic Cancers Patients
M.D. Anderson Cancer Center
Completed
NCT01518023 2012-01-25
Long Term Diabetes Improvement After Cancer Gastrectomy and Colectomy
University of Sao Paulo
Completed